New cholesterol guidelines and questions about drug company influence
New cholesterol and heart disease guidelines are about to come out for the first time in several years. Sunday on Full Measure, we’ll investigate the controversy over past national guidelines which, we learned after the fact, were written by a lot of doctors compensated by the makers of cholesterol-lowering statin drugs. As it happens, the guidelines basically say millions more Americans should take statins. Some researchers argue there’s a serious conflict of interest there– and in the writing of other national health guidelines. We’ll dig into the Statin Wars.
Brazilians have elected a new President– some call him Brazil’s version of Donald Trump. Jonathan Elias reports from Brazil on why a nation in crisis is taking a right political turn.
Lisa Fletcher looks at greyhound racing which may be on its last legs in Florida depending on a vote Tuesday. Critics say the sport is cruel to the animals, which can be injured or mistreated. Supporters say it provides a livelihood of thousands of Floridians.
Original reporting you won’t see anywhere else! We won’t waste your time rehashing news you’ve already seen all week.
Watch us on TV or replays online anytime, livestream Sundays at 9:30a ET www.fullmeasure.news
More original stories you won’t see anywhere else. Watch on TV or online at www.fullmeasure.news!
Order the New York Times bestseller “The Smear” today online or borrow from your library
Original source: https://sharylattkisson.com/2018/11/02/new-cholesterol-guidelines-and-questions-about-drug-company-influence/
See comments at original source: https://sharylattkisson.com/2018/11/02/new-cholesterol-guidelines-and-questions-about-drug-company-influence/#comments
